ARTICLE | Company News
Aeterna Zentaris, ComGenex deal
February 7, 2005 8:00 AM UTC
AEZ's Echelon Biosciences Inc. unit (Salt Lake City, Utah) acquired exclusive rights to develop, manufacture and market certain PI3 kinase inhibitors for cancer discovered through a joint discovery p...